-
Study aim
-
Diminished ovarian reserve (DOR) significantly decreases the success rate of Assisted Reproductive techniques (ART). In this study we study the effect of melatonin on the follicular oxidative stress and quality of oocyte and embryo in women with Diminished ovarian reserve .
-
Design
-
This study is a randomized, double-blind, placebo-controlled clinical trial.
-
Settings and conduct
-
In this research, an intervention group including 38 patients with reduced ovarian reserve (based on entry and exit criteria) three months after taking one melatonin tablet (3 mg melatonin tablet Hakim) per day and a control group that received a placebo.The patient and the doctor do not know the contents of the package (melatonin tablets and placebo).
-
Participants/Inclusion and exclusion criteria
-
ART for the first time, normal male factor, normal uterine cavity and presence of two of the three following criteria first; summation of bilateral AFC ≤ 6, second; AMH≤1 and third; basal FSH on the 3rd day of menstrual cycle≥10.
If the couple decline to participate, the protocol is not exactly followed or the ovaries showed poor responses to gonadotropins the cases are excluded from the study.
-
Intervention groups
-
In the case group ,the paitent recieve melatonin by does of 3 mg/day from 5'th day of sycle till pick-up day.in the control group ,the paitent recieve pelacebo capsule one every night from 5'th day of sycle till pick-up day .
-
Main outcome variables
-
The main outcomes in this plan arethe level of sex hormones, the number of follicles, the number and quality of oocytes and embryos, measuring the level of superoxide dismutase, the expression of GDF9 (Growth Differentiation Factor 9), and BMP15(Bone Morphogenetic Protein 15) and (nuclear factor erythroid 2–related factor 2)NRF -2genes which will be measured before and after the intervention.